New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

Generic drug maker Apotex Inc. caught the market by surprise yesterday, launching a cheaper copy of the best-selling, blood thinner Plavix in the United States ahead of a likely patent infringement ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

Those looking to save on the new generic Plavix clopidogrel are in luck. We phoned 30 pharmacies around the U. None of the pharmacies had the mg dose available. The blockbuster drug, first approved by ...

Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any ...

The Justice Department is investigating a deal between two large brand-name drug makers and a generic company. The deal allegedly was made to keep a cheaper, generic form of Plavix off the market for ...

PARIS, Oct 31 (Reuters) - Sanofi-Aventis posted a better than expected third-quarter profit on Tuesday due to generic rivalry to heart drug Plavix and government health cuts. The world's third-largest ...